Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
Brain and Behavior
Saved in:
Main Authors: | Molassiotis, A., Cheng, H.L., Leung, K.T., Li, Y.C., Wong, K.H., Au, J.S.K., Sundar, R., Chan, A., Ng, T.R.D., Suen, L.K.P., Chan, C.W., Yorke, J., Lopez, V. |
---|---|
Other Authors: | ALICE LEE CENTRE FOR NURSING STUDIES |
Format: | Article |
Language: | English |
Published: |
WILEY
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/206770 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Risk factors for chemotherapy-induced peripheral neuropathy in patients receiving taxane- and platinum-based chemotherapy
by: Molassiotis, A., et al.
Published: (2021) -
Redefining chemotherapy-induced peripheral neuropathy through symptom cluster analysis and patient-reported outcome data over time
by: Wang, Mian, et al.
Published: (2021) -
Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group - Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
by: Cheng, H.L., et al.
Published: (2021) -
Management options for established chemotherapy-induced peripheral neuropathy
by: Pachman, D.R., et al.
Published: (2016) -
The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): Validation of English version in Singapore
by: Luo, N., et al.
Published: (2014)